KENVUE INC. LONG-TERM INCENTIVE PLAN GLOBAL NONQUALIFIED STOCK OPTION AWARD AGREEMENTGlobal Nonqualified Stock Option Award Agreement • March 1st, 2024 • Kenvue Inc. • Perfumes, cosmetics & other toilet preparations • Delaware
Granted To: #ParticipantName# Grant Date: #GrantDate# WWID #: #EmployeeID# Total Shares: #QuantityGranted# Vesting Commencement Date: December 1, 2023 Purchase Price Per Share: $20.81 Scheduled Vesting Date: The dates set forth in the table below (each, a “Scheduled Vesting Date”).
Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program Global Nonqualified Stock Option Award AgreementGlobal Nonqualified Stock Option Award Agreement • February 14th, 2022 • Edwards Lifesciences Corp • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
THIS AGREEMENT, including any appendix for the Participant’s country (the “Non-U.S. Countries Additional Terms Appendix”), the appendix containing additional defined terms (the “Additional Defined Terms Appendix” and, together with the Non-U.S. Countries Additional Terms Appendix, the “Appendices”) and the Participant Stock Option Statement attached to the front of this agreement (the “Statement”), sets forth the terms and conditions of the nonqualified stock option (the “Option”) granted by Edwards Lifesciences Corporation, a Delaware corporation (the “Company”), to the Participant named on the Statement, pursuant to the provisions of the Company’s Long-Term Stock Incentive Compensation Program (the “Program”). This agreement, the Appendices and the Statement shall be considered one agreement and are referred to herein as the “Agreement.”
JOHNSON & JOHNSONGlobal Nonqualified Stock Option Award Agreement • May 1st, 2018 • Johnson & Johnson • Pharmaceutical preparations • California
In addition to such other conditions as may be established by the Committee, in consideration of the granting of an award under the terms of the Johnson & Johnson 2012 Long-Term Incentive Plan, as amended from time to time (the “Plan”), you agree as follows:
